Docusign has suffered an 85% decline from COVID-era highs, with further 2026 losses amid SaaS sector weakness. I see DOCU as an undervalued utility-like enterprise provider, trading at bargain-basement multiples despite stable, if unexciting, growth. Recent Q1 results showed slight revenue growth improvement and a raised full-year outlook, yet DOCU missed the broader market rally.
On June 25, 2026, Docusign Inc (DOCU) shares fell 4.0% to a current price of $42.46. This decline comes amid a challenging year for the company, with its stock
DocuSign (DOCU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Docusign for Perplexity Computer helps in-house legal teams draft, review, sign, and manage contracts across the entire business SAN FRANCISCO, June 24, 2026 /PRNewswire/ -- Docusign (NASDAQ: DOCU) today announced that its Intelligent Agreement Management (IAM) platform is now available for Perplexity Computer and Computer for Counsel, enabling legal teams and businesses to automate contract workflows with AI. The Docusign integration helps in-house legal teams spend less time on manual contract tasks and more time on strategic work by making it easier to collaborate with sales, procurement, HR, and other teams on contracting work.
Businesses can now access agreement insights, automate workflows, and take action directly within Slack, a Salesforce Company SAN FRANCISCO, June 18, 2026 /PRNewswire/ -- Docusign (Nasdaq: DOCU) announced a new app for Slackbot, available today, that connects to Slackbot through Model Context Protocol (MCP), bringing the Docusign Intelligent Agreement Management (IAM) platform directly into the conversations where work happens. Powered by the Docusign Iris AI engine, the app helps teams access agreement intelligence, automate workflows with agents, and take action on agreements using natural language within Slack.
On June 17, 2026, Docusign Inc (DOCU) shares fell 4.2% today, closing at $42.58. This decline adds to a challenging year for the company, with its stock down 37